Voyager Therapeutics (VYGR): Strong Q3 Prompts Bullish Coverage
On November 12, HC Wainwright lowered the price target on Voyager Therapeutics, Inc. (NASDAQ:VYGR) to $25 from $30 and kept a Buy rating on the shares.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | EcoR1 Capital Oleg Nodelman | 4,002,847 | $15,731,189 | +498% | 0.71% |
| 2. | Armistice Capital Steven Boyd | 4,000,000 | $15,720,000 | -5% | 0.19% |
| 3. | Millennium Management Israel Englander | 1,880,760 | $7,391,387 | -18% | 0% |
| 4. | Vestal Point Capital Ryan Wilder | 1,475,000 | $5,796,750 | 0.2% | |
| 5. | Opaleye Management James A. Silverman | 1,196,904 | $4,703,833 | 0.62% |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.88 | 4,395,588 | $39,032,821.44 | 8,575,316 | 2023-02-23 | Filing | |
| $5.66 | 376,000 | $2,126,543.20 | 4,753,907 | 2022-06-23 | Filing | |
| $5.28 | 101,400 | $535,503.54 | 4,377,907 | 2022-06-21 | Filing | |
| $11.96 | 4,179,728 | $49,999,996.20 | 4,179,728 | 2019-03-12 | Filing | |
| $19.39 | 3,000 | $58,170.00 | 76,588 | 2018-09-10 | Filing |
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.44 | 3,882 | $13,354.08 | 206,196 | 2026-02-18 | Filing | |
| $3.44 | 3,301 | $11,355.44 | 149,892 | 2026-02-18 | Filing | |
| $3.41 | 11,732 | $40,006.12 | 498,257 | 2026-02-18 | Filing | |
| $3.85 | 4,569 | $17,590.65 | 210,078 | 2026-02-10 | Filing | |
| $3.78 | 12,192 | $46,085.76 | 509,989 | 2026-02-10 | Filing |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,618,365 | $22,080,174 | 0% | |
| 2. | 3,266,484 | $12,837,282 | 0% | |
| 3. | 1,195,141 | $4,717,683 | 0.04% | |
| 4. | 1,135,188 | $4,462,072 | 0% | |
| 5. | 1,084,499 | $4,262,123 | 0% |